Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Navidea Biopharmaceuticals Inc (NAVB)

Navidea Biopharmaceuticals Inc (NAVB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Navidea Biopharmaceuticals Inc 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 USA

P: 614-793-7500

Description:

Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio.

Key Statistics

Overview:

Market Capitalization, $K 7,990
Enterprise Value, $K 3,760
Shares Outstanding, K 32,151
Annual Sales, $ 530 K
Annual Net Income, $ -11,730 K
Last Quarter Sales, $ 10 K
Last Quarter Net Income, $ -5,710 K
60-Month Beta 1.36
% of Insider Shareholders 45.20%
% of Institutional Shareholders 5.55%
Float, K 17,619
% Float 54.80%
Short Volume Ratio 0.26

Growth:

1-Year Return -78.01%
3-Year Return -76.41%
5-Year Return -97.18%
5-Year Revenue Growth -97.59%
5-Year Earnings Growth 77.78%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.25 on 11/14/22
Next Earnings Date 11/15/22
Earnings Per Share ttm -0.57
EPS Growth vs. Prev Qtr -150.00%
EPS Growth vs. Prev Year -212.50%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 04/26/19

NAVB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -322.92%
Profit Margin % -2,213.21
Net Margin % N/A
Debt/Equity N/A
Price/Sales 15.14
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.15
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar